PIDILITIND / guidance tracker

Keep management guidance in view.

Pidilite Industries · forward-looking guidance across the available source record.

Research layer active

Guidance tracker

What management said would happen.

EBITDA margin band maintained at 20%-24%

Management comfortable with current range despite potentially higher margins in Q1, stating going beyond 24% would impede volume growth and open back door to regional competitors.

margins

Volume growth target: 1.5x-2x GDP

Core categories expected at 1x-1.5x GDP, growth categories at 2x-3x GDP, with portfolio mix shifting to 60% core / 40% growth+pioneer by year-end.

growth

CapEx commitment: 3.5%-4.5% of sales

Company will continue investing in capacity with 3-4 new plants annually, having commissioned 7 plants YTD including Roff, construction chemicals, and JV facilities.

capex

Rural distribution expansion continuing

Added 17,000 new villages and 8,000+ Pidilite Ki Duniya stores in past 12 months; targeting deeper rural reach with same product range but smaller packs.

expansion

Double-digit UVG target maintained for FY25

Management reiterated full-year underlying volume growth guidance of 10%+ for FY25, barring any black swan events, supported by stable pricing environment and robust rural momentum.

growth

Value-volume convergence expected from Q2, stabilization in H2

If input prices remain stable and no major geopolitical disruptions occur, management expects value growth to converge with volume growth starting Q2 and definitely by H2, as pricing actions from FY24 roll off.

revenue

EBITDA margins to remain at higher end of 20-24% band

Current margin of 24.6% expected to sustain near higher end of the range through FY25 if input costs remain benign, with scope to reinvest savings into brand building if margins compress.

margins

Rural to grow at 1.5x urban rate over next 2-3 years

Internal target maintains rural growth at 1.5x urban, supported by continued expansion of Pidilite Ki Duniyas network and penetration opportunity in existing accounts (90% of growth is same-store, not new stocking).

growth

FY26 EBITDA margin at higher end of 22-24% corridor

Management explicitly stated chances are 'quite high' of landing at the higher end of the 22-24% EBITDA margin corridor for FY26, citing benign input costs and operating leverage. Q1's 25.6% margin was inflated by seasonal factors and lower A&P spend.

margins

Sustained double-digit B2B volume growth

Management confident of delivering 'double-digit robust underlying volume growth' in B2B for the remainder of FY26, driven by strong project business momentum and offsite/joinery sub-segments.

growth

Maintain or improve 9.9% UVG run-rate

Given uniform growth across regions, categories, and product groups, plus demand sentiment tailwinds from Budget cash transfers and RBI liquidity measures, management expressed confidence in sustaining underlying volume growth.

growth

Pricing to remain tactical at ~70 bps contribution

No across-the-board price increases expected given benign input cost environment. Pricing contribution to revenue growth to remain in the 50-80 bps range, purely tactical in nature.

pricing

EBITDA margin to remain within 20%-24% range

Margins expanded 600bps YoY to 23.2%, but VAM prices have started firming from lows. Management prioritizes volume growth over margin expansion, with no additional price cuts currently planned unless input windfalls recur.

margins

Volume-value gap to bridge in two quarters

The 4-5% gap between 8% volume growth and lower value growth reflects cumulative price reductions taken. With last price reduction in Q2, management expects value growth to normalize toward volume growth within two quarters.

revenue

Targeting double-digit volume growth

Current quarter's 8.2% UVG was impacted by extreme wet weather disruptions in July (warehouse out of action for 7 days). Management aims to return to double-digit volume growth in next 3-6 months, with 1.5x real GDP as long-term structural target.

growth

NBFC pilot limited to single geography

Lending business being piloted in one region with separate heavyweight team. Post-pilot learnings, all options on table including asset-light partnerships. Capital exposure will be limited; pilot size is INR 100 crore over two years before scale decisions.

expansion

Double-digit UVG target for FY25 maintained

Management reaffirmed commitment to double-digit underlying volume growth for full year, planning H2 uptick from improved government capex, favorable monsoon tailwinds, and rural income benefits.

growth

H2 EBITDA margins expected at higher end of 20-24% range

Avi Mehta questioned whether H1 margin of 24.6% signals range breach; management clarified A&P spend was deferred to H2/H3, which will normalize margins back toward historical range ceiling.

margins

Q3 VAM prices stable at $800-900/ton

Current VAM procurement is between $800-900/ton depending on timing; Q3 expected to be "very similar to Q2" in terms of raw material index, with some other inputs seeing price increases.

margins

Paint venture update deferred to March 2025

Paints initiative in four southern states (covering <1/3 of India) will be evaluated after full festive season cycle including Pongal in January; current impact on group growth is immaterial.

expansion

Double-digit UVG continuation in H2 FY26

Management expressed confidence in sustaining double-digit underlying volume growth in the second half, supported by strong demand generation model and portfolio breadth.

growth

VAM prices benign for 3-6 months

Input cost environment expected to remain favorable with VAM below $900/MT for the next three to six months, though visibility beyond that is limited.

margins

A&P investment in 3%-5% ANSP corridor

Gross margin expansion from benign inputs will be judiciously deployed into advertising and sales promotion (currently at 4.2% of sales), targeting the higher end of the 20%-24% EBITDA margin corridor if raw material tailwinds persist.

margins

Capex maintained at 3%-5% of sales

Capital expenditure will remain in the 3%-5% of sales range, with faster-growing categories like RAF and Dr. Fixit receiving proportionally higher allocation for capacity expansion.

capex

Double-digit UVG target maintained

Management reiterated the organization's objective of delivering double-digit underlying volume growth, not tonnage growth. Currently delivering in that range and confident of maintaining trajectory barring black swan events.

growth

EBITDA margin range of 20-24%

Stated confidence in maintaining 20-24% EBITDA margin band. With current benign input costs, margins will tend toward higher end. Will continue investing in A&P while protecting profitability.

margins

Advertising & sales promotion investment

In first 9 months of FY24, investment in A&P has nearly doubled YoY to support volume-led profitable growth and maintain brand premium.

growth

Innovation contribution target

One-third of total growth must come from innovations launched in the last 24 months, including premium variants (Fevicol Hi-Per), new sealant range, and PU/polyurea waterproofing products.

growth

Demand Recovery Timeline

Management expects demand to remain muted through Q4 FY25, with improvement anticipated in Q1 FY26 driven by budget impact and improved disposable income.

growth

VAM Input Cost Guidance

VAM consumption expected to remain around $884/ton in Q4 FY25, give or take 1-2%, maintaining benign input cost environment.

margins

EBITDA Margin Range

Margins expected to remain in the 20-24% range as management will invest incremental margin gains back into growth stimulation.

margins

Rural Distribution Runway

Two to three-year runway remains before rural consumption reaches income-equalized urban levels, supporting continued distribution expansion.

expansion

Full-year EBITDA at upper end of 20%-24% range

While Q3 margins are above the range, management expects full-year to land at the upper end of the 20%-24% corridor as gains are reinvested into growth initiatives.

margins

Pricing growth of 100-150 bps sustainable

Sustainable price growth of 100-150 bps expected going forward, though not as a formulaic quarterly target; tactical pricing opportunities continue to be identified.

pricing

Export headwinds largely behind by Q4

Management expects export decline to moderate from Q4 onwards as US tariff clarity materializes; B2B plans and alternate geographies (EU, others) will support recovery.

growth

Domestic B2B targeting mid-teens growth

Domestic B2B business, which delivered mid-teens growth, is expected to return to double-digit/mid-teens trajectory with plan Bs in place.

growth

FY25 Volume Growth: As good as FY24

Management expects FY25 volume growth to match or exceed FY24's double-digit performance, assuming no geopolitical black swan events. Near-term Q1 disruption from elections expected to reverse within 30-45 days.

growth

FY25 EBITDA Margin: 20-24% range

Margins targeted in the 20-24% band for FY25, comfortable range excluding extreme commodity scenarios. Normal course of business should sustain margins within this guidance.

margins

A&P Spend: 4-4.5% of revenue

Advertising spend expected to normalize to 4-4.5% of revenue from FY24's elevated 70% YoY increase. New Fevicol campaign launching within 15 days per MD's comment.

growth

CapEx: 3-5% of revenue

Capital expenditure guidance maintained at 3-5% of revenue for FY25. All new capacity expansion expected to be PBT-accretive at full utilization with efficiency gains in freight and conversion costs.

capex

Double-digit UVG target for FY26

Management reaffirmed commitment to delivering double-digit profitable underlying volume growth in FY26, citing improved consumer demand, government spending post-elections, and favorable monsoon forecast as key drivers.

growth

B2B growth sustainability

Management expressed confidence in sustaining low-to-mid-teens B2B growth for 2-3 years, driven by Pidilite Professional Solutions division targeting construction sector through integrated approach to architects, consultants, and EPC contractors.

growth

Construction chemicals growth trajectory

Dr. Fixit and Roff (tile adhesives) categories expected to continue delivering 2x-4x GDP growth rate through expanded go-to-market initiatives including DSCs (Dr. Fixit Centers) and category-specific strategies.

growth

EBITDA Margin Corridor: 20%-24%

Management reiterated commitment to the 20-24% EBITDA margin band. With benign input costs in FY26, margins were at higher end; with current raw material inflation (~40-50%), FY27 margins expected to be lower but remain within the band.

margins

Targeting ~100bps UVG Expansion Annually

Management's stated intent is to systematically raise underlying volume growth by approximately 100 basis points each year. FY26 UVG of 11.3% was 120bps higher than FY25's 9.3%. This trajectory is the planning objective.

growth

Price Hikes: Calibrated Pass-Through Strategy

Company took ~4-5% blended price increase in mid-April and ~7-8% in early May, totaling ~12-15% for VAM-intensive categories. Strategy is to pass through absolute rupee cost increases in calibrated, staggered fashion while maintaining growth focus. If West Asia conflict resolves quickly, price relief may need to be passed back.

pricing

CapEx Budget: 3-5% of Revenue

FY26 CapEx was ~INR 570 crore vs ~INR 430 crore in prior year. Three CapEx buckets: (1) growth CapEx for capacity augmentation, (2) automation/consolidation for core categories including premium white glue plant commissioning in Q1 FY27 West India, (3) newer categories/areas.

capex